Context: Oxytocin plays an important hormonal role in the regulation of feeding and energy intake. Objective: The aims of this review were to 1) determine the effects of dietary intake/behaviors on endogenous oxytocin and 2) examine the effect of exogenous oxytocin on dietary intake/behaviors. Data sources: Published studies up to December 2016 were identified through searches of 5 electronic databases. Data extraction: Eligible studies included those in adults that included a measure related to an individual's diet and a measure of oxytocin and the relationship between the 2 outcomes. Results: Twenty-six studies (n ¼ 912 participants; 77% female) were included. The most common dietary outcomes assessed were alcohol, caffeine, calcium, sodium, fat, and calorie intake. It was found that endogenous oxytocin (n ¼ 13) in nonclinical samples did not change significantly (P > 0.05) through altered diet or behaviors (neutral effect); in contrast, significant (P < 0.05) differences (increases and decreases) were identified in clinical samples. Exogenous oxytocin studies (n ¼ 13) found reduced indices of food intake (positive effect) in clinical and nonclinical samples. Conclusions: Overall, few studies included comprehensive investigation of dietary intakes through the use of validated assessment tools. Dietary intake and behaviors appear to have some influence on oxytocin, with more pronounced effects found with exogenously administered oxytocin.
INTRODUCTION
The dietary intake patterns and behavior of humans depend on the complex interplay of many neuroendocrine processes within the body. 1 The neurophysiological mechanisms that modulate these processes involve a network of pathways that are regulated by an intricate feedback system. [1] [2] [3] These processes are sensitive to emotional and cognitive control, as well as external influences, such as environmental cues and food availability. 3 Research in animal models and pilot studies in humans have indicated that oxytocin can play an important role in food intake, metabolism, and brain reward functions. 2, 4 Oxytocin, a neuropeptide produced primarily in the paraventricular and supraoptic nuclei of the hypothalamus, is secreted by the pituitary gland in response to a variety of interactive behaviors and stimuli involved in food motivation and food intake. 5, 6 The role of oxytocin includes the regulation of feeding, energy intake, and expenditure, in conjunction with related aspects such as controlling appetite and satiety. 5, 7, 8 Animal studies support a hypothesis that oxytocin can function as an anorexigenic hormone. For example, centrally (via intracerebroventricular application) and peripherally (via subcutaneous or intraperitoneal application) administered oxytocin significantly reduces overall food intake, [9] [10] [11] [12] as well as alcohol, 13, 14 sucrose, 15, 16 and saccharin 17 intakes in both obese and lean animals (all P < 0.05). Additionally, oxytocin has been found to increase the latency to begin feeding and reduce meal durations in both hungry and satiated animals. 10, 11, 18, 19 Furthermore, pretreatment with oxytocin receptor antagonists blocked these anorexigenic actions. [20] [21] [22] Oxytocin knockout mice also display significantly increased preferences for sucrose, 23, 24 saccharin, 25 and sodium compared with wild-type controls (all P < 0.05). 26, 27 Oxytocin is best known for its hormonal role in reproductive function in women, particularly childbirth and lactation. 28 Oxytocin is also known to fluctuate at various times throughout the menstrual cycle, with higher concentrations during the follicular and ovulatory phases. 29, 30 Of late, oxytocin has been recognized for its influence in neurophysiological behaviors, such as social recognition, stress, trust, and empathy. [31] [32] [33] [34] [35] Furthermore, oxytocin has been associated with psychiatric disorders, such as autism spectrum disorder, 29 schizophrenia, 36 depression, and anxiety, 34 and addictive disorders, such as drug and alcohol abuse. 31 It has been suggested that individuals with psychiatric conditions and those exhibiting addictive behaviors have decreased oxytocin levels. 31, 37 Many of the psychosocial characteristics that are common to these disorders are also common to the pathologies of disturbed eating patterns, such as anorexia nervosa (AN), binge eating, and obesity. [38] [39] [40] [41] More recently, research has investigated oxytocin in relation to addictive eating behaviors. 42 Traditionally, research has focused on the contribution of endogenous oxytocin (ie, oxytocin produced and secreted within the body in response to stimuli 5 ) in the regulation of food intake and eating behaviors. During the last decade, several preclinical studies have found that administration of exogenous intranasal oxytocin inhibits eating behaviors driven by hunger and extends to limiting the intake of palatable food. [43] [44] [45] To date, published studies examining the effects of endogenous or exogenous oxytocin in relation to human nutrition have not been systematically reviewed. To promote further understanding, examination of the neuropeptide and its role in dietary intake is warranted. Oxytocin may present as a biomarker of disordered eating patterns, which could have implications for characterizing disordered eating patterns and the comorbidities associated with these behaviors. Exogenous oxytocin administration may offer a potential therapeutic approach to moderate dietary intake and behaviors.
This systematic review aims to examine published literature to determine the interrelationship between diet and oxytocin in adults. The primary objectives are 1) to examine the effect of dietary intake/behaviors on endogenous oxytocin and 2) to examine the effect of exogenous oxytocin on dietary intake/behaviors.
METHODS

Study criteria
To be included in this review, a study had to be conducted in an adult population or a population sample in which the majority of individuals were over the age of 18 years. The study needed to include 1) an outcome measure related to the individuals' dietary intake (ie, food or nutrient) and/or behavior (eg, meal consumption patterns), 2) an outcome measure of endogenous oxytocin (eg, cerebrospinal fluid blood [CSF] , plasma, urine, or saliva) or exogenous oxytocin administration, and 3) the relationship between the 2 measures. For outcomes related to dietary behaviors, measures included behavioral responses associated with eating (eg, craving, satiety, and appetite), behavioral models of eating (eg, AN, binge eating), patterns, and time intervals of eating (eg, fasting). To maintain homogeneity of the outcomes and clearly define the interrelationship between oxytocin and specific dietary intake patterns or behaviors, studies examining the physiological mechanisms of metabolism and digestive processes (eg, gastric emptying rates, sodium clearance rates) are not included in the present review.
For the purposes of this paper, all study designs were considered; exclusion criteria were narrative reviews, case reports/series, commentaries, editorials, letters to the editor, theses, and conference proceedings. Because of the range of experimental approaches used in preclinical studies, reports that involved animal populations were excluded. Additionally, human studies that focused on pregnant or lactating female participants, in whom there is expected biological changes in oxytocin levels and hormonal-related alterations in food intake and eating behaviors, and studies that focused on populations with health conditions/diseases known to alter oxytocin function (eg, pituitary gland disorders) were excluded. The review methodology was prospectively registered in the International Prospective Register of Systematic Reviews (PROSPERO registration number: CRD42016053015) and follows Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines 46 ( Table 1) . In addition, to ensure no relevant articles were missed, a manual search of the reference lists of relevant publications was conducted. Duplicate articles were first removed, and articles were manually coded as human participants or animal subjects. Articles based on animal research, along with human studies focusing on pregnant or lactating female participants, were excluded. The remaining title and abstracts identified through the search were imported into Covidence 47 (Web-based screening tool) and screened by 2 independent reviewers using the predetermined inclusion/exclusion criterion. For abstracts that met the inclusion criteria, or where eligibility was unclear, full-text articles, including supplementary materials, were retrieved for further screening. These were then evaluated for inclusion by 2 independent reviewers, with discrepancies resolved by discussion with a third reviewer. Consensus was reached for all included articles.
Search strategy
Data extraction
Data extraction was conducted using a standardized table developed for this review. The tool was pilot tested on 6 randomly selected included studies and refined to ensure all relevant data were being captured. One review author extracted the data from included studies, and a second author independently checked the extracted data.
Data synthesis
Most studies in this systematic review were highly diverse with regard to study design, participants, clinical characteristics, interventions, and outcome measures presented. Additionally, endogenous oxytocin measurements were performed using different assay methods and in a range of biological fluids (saliva, CSF, unextracted and extracted serum), which is known to influence findings. [48] [49] [50] Therefore, a meaningful metaanalysis was not possible, and studies are described in a narrative summary.
Quality of evidence
The risk of bias and strength of evidence from individual studies was assessed by 2 independent reviewers using a standardized tool from the American Academy of Nutrition and Dietetics. 51 This 10-point checklist, which includes 4 validity criteria questions, assesses population bias, study blinding, description of the intervention and assessment tool, statistical methods, and study funding. The quality of evidence for each outcome was rated as being absent, present, or unclear in each study. An overall quality rating was assigned, with each study being rated as positive (4 validity criteria plus !1 additional criteria met), neutral (overall 4 criteria met, but <4 validity criteria met), or negative (overall <4 criteria met). No studies were excluded based on quality ratings. In cases of uncertainty regarding quality assessment, a third independent reviewer was consulted until consensus was reached.
RESULTS
Description of studies
The search strategy, summarized in Figure 1 , identified 1635 potentially eligible articles after exclusion of duplicates. After the removal of animal studies and human studies focusing on pregnant or lactating female participants, the search strategy yielded 412 articles for initial screening. Initial screening of titles and abstracts identified 115 articles, which received a detailed assessment of the full-text article. Of these, 91 were excluded because they did not meet the inclusion criteria. The wrong study design (n ¼ 67; eg, narrative review articles, commentaries, and conference abstracts) was the main reason for exclusion. A total of 24 articles (n ¼ 26 studies) are presented in the current review.
42-45,52-71
Quality of included studies
The quality assessment appraisals of included studies deemed 24 studies as having a positive rating and 2 as having a neutral rating (Table S1 in the Supporting Information online). The studies rated as neutral comprised study groups that were not comparable; in addition, study limitations and biases were not described. 58, 62, 66 binge-eating disorder (BED; n ¼ 1), 71 and food addiction (n ¼ 1). 42 Participants were recruited from 7 countries: United States (n ¼ 7 studies), 44, 52, 55, 58, [62] [63] [64] [65] Germany (n¼ 4), 43, 45, 59, 70 Italy (n ¼ 3), 56, 57, 71 Sweden (n ¼ 4), 53, 54, 67, 68 South Korea (n ¼ 2), 60, 61 Denmark (n ¼ 1), 69 and Canada (n ¼ 1). 42 Participants ranged in age from 16 to 65 years (mean, 31.1 6 9.0). The average age of participants was < 45 years for all but 2 studies. 53, 71 Across all of the included studies, the most common secondary measures examined, in descending order, were appetite hormones and blood parameters (n ¼ 8), mood states (n ¼ 5), gastric emptying rates (n ¼ 3), energy expenditure (n ¼ 3), anxiety and depression (n ¼ 3), temperament traits (n ¼ 2), emotional recognition (n ¼ 2), and autism spectrum traits (n ¼ 1).
Endogenous oxytocin studies
Thirteen of the selected studies (Table 2 42-45,52-71 ), which were published between 1991 and 2016, examined the effects of dietary intake and behaviors on endogenous oxytocin in healthy individuals (n ¼ 7) 52,55-57, 59,64,69 and individuals with clinical characteristics (n ¼ 6; T1DM, chronic normal-transit constipation, AN, BN, and food addiction). 42, 58, 62, 63, 66, 68 Sample sizes ranged from 4 to 162 (median, 24). Over half of the studies (n ¼ 7) included female participants exclusively, 56, 58, [62] [63] [64] 66, 68 4 included only male participants, 52 ,55,57,69 and 2 included both male and female participants. 42, 59 Participants ranged in age from 16 to 43 years (mean, 28.9 6 6.4).
Exogenous oxytocin studies
Thirteen studies (Table 2 42-45,52-71 ), which were published between 2006 and 2016, examined the effect of exogenous oxytocin on dietary intake and behaviors in healthy individuals (n ¼ 8) [43] [44] [45] 54, 65, 67, 70 and individuals with clinical characteristics (n ¼ 5; functional dyspepsia, gastroparesis, AN, BN, and BED). 53, 60, 61, 71 Sample sizes ranged from 10 to 102 (median, 20) . Four of the studies included female participantss exclusively, 60, 61, 70, 71 3 included only male participants,  43-45 and 5 included both  male and female participants. 53,54,65,67 Participants ranged in age from 16 to 62 years (mean, 34.1 6 11.1).
Dietary characteristics and assessment methods
The studies varied in the particular dietary characteristics examined (Table 2 42-45,52-71 ). Endogenous oxytocin concentrations were examined in relation to the following dietary exposures, intakes, and behaviors, in descending order: alcohol (n ¼ 6), eating disorders (AN and BN; n ¼ 3), caffeine (n ¼ 1), dietary and supplemental calcium (n ¼ 1), fat-rich meal (n ¼ 1), low-and high-sodium diets (n ¼ 1), short-term fasting (n ¼ 1), and food addiction (n ¼ 1). The dietary intake and behaviors examined following exogenous oxytocin administration included the following: appetite and satiety (n ¼ 8), consummatory behavior (food or volume intake; binge eating; n ¼ 6), craving (n ¼ 3), and attentional biases to diet-related stimuli (n ¼ 2).
Dietary assessment methods were highly varied across the included studies, and very few (n ¼ 5) provide information about use of a validated measure. Two cross-sectional studies that used a validated foodfrequency questionnaire assessed macro-and micronutrient intakes in relation to plasma oxytocin levels. 42, 62 Following oxytocin and/or placebo administration, 2 studies assessed food intake relevant to the eating pathologies of the specific populations being studied, rather than specific nutrient intakes. For instance, in individuals with BED, a self-report diary was kept over the 8-week intervention period to monitor binge-eating episodes, including the types of foods consumed. 71 In individuals with AN and BN, a food diary was recorded for 24 hours following oxytocin administration to quantify calories consumed after intervention. 60 Lawson et al. 44 used a 72-hour preintervention self-reported food diary to track food intake prior to the first experimental procedure. This allowed participants to replicate a similar food intake pattern prior to their second study visit. In three experimental crossover studies, participant's usual intakes of alcohol 52, 59, 64 were recorded prior to experimental dietary exposures. 44 However, these studies did not describe the dietary assessment method used, and intakes were not directly compared with oxytocin concentrations. Within these studies, usual alcohol intake was used as an a priori measure to ensure inclusion criteria were met (ie, abstainers or abusers of alcohol were excluded). Self-report questionnaires and semistructured interviews were the main assessment methods used to measure eating disorders (AN and BN) and BED symptoms and behaviors (n ¼ 6). 58, 60, 61, 63, 66, 71 Plasma OT assessed on 2 consecutive days (radioimmunoassay of extracted serum). Blood drawn every 10 min from 0900 (day 1) to 1600 h (day 2) ¼ total of 186 blood draws.
Fasting occurred from 1300 h on day 1, to study completion, 1600 h on day 2 (continued) Of the 16 studies that measured the effect of a dietary exposure, compliance was measured in 11 studies through biomarkers, 69 blood alcohol concentrations, 52, 57, 59, 64 or weighed food designs. [43] [44] [45] 60, 61, 63 Effect of dietary intake and behavior on endogenous oxytocin
Of the 13 studies that examined dietary intake and behaviors on endogenous oxytocin (Table 2 
Alcohol intake
Six studies assessed alcohol intake in relation to endogenous oxytocin. 52, 56, 57, 59, 62, 64 One cross-sectional study 62 found alcohol intake was associated with decreased plasma oxytocin levels in premenopausal women with T1DM, but not in nondiabetic matched controls. Across the 5 placebo-controlled crossover trials, 52 ,56, 57,59,64 4 studies found alcohol had no significant effect on plasma oxytocin concentrations in either male or female participants (all P > 0.05), 52, 56, 57, 59 and a nonsignificant decrease was found in 1 study in female participants (P ¼ 0.07). 64 The types of alcoholic beverages consumed varied among studies and included alcohol mixed with fruit juice (n ¼ 2), ethanol mixed with whisky (n ¼ 2), and beer (n ¼ 1). The dosages also varied, and it is estimated that low to high doses ranging from approximately 10 to 70 grams of alcohol were consumed. Beverage consumption was monitored over a 15-30-minute period.
Eating disorders
Of the studies that examined eating disorders (n ¼ 3), 2 studies found peripheral and central oxytocin levels to be lower in individuals with AN than those with BN or healthy controls. 58, 66 When restrictive and binge/purging AN subtypes were compared, Monteleone et al. 66 found no significant differences in plasma oxytocin levels between the 2 subtypes (P > 0.05), whereas Demitrack et al. 58 found significantly lower CSF oxytocin concentrations in restrictive AN (P < 0.04). During the course of recovery, Demitrack et al observed a significant increase in oxytocin levels in individuals with all types of AN (P < 0.01). In contrast, Lawson et al. 63 found baseline and postprandial oxytocin levels to be significantly lower in individuals with weight-recovered AN compared with individuals with AN and controls (P < 0.05).
Other dietary measures
Of the studies that examined other dietary measures (n ¼ 5), 1 study 62 found caffeine intake and calcium supplement use were associated with increased plasma oxytocin levels in women with T1DM, but not in nondiabetic matched controls. A fat-rich meal was found to significantly increase plasma oxytocin levels (P < 0.05), 68 whereas varying levels of sodium intake (30-690 mmol NaCl/d) did not alter plasma oxytocin levels (P > 0.05). 69 There was no significant difference in plasma oxytocin found in food-addicted versus nonfood-addicted obese participants (P ¼ 0.78) 42 or in male participants in a short-term fasted (%24 h) versus a fed state (P > 0.05). 55 
Effect of exogenous oxytocin on dietary intake and behaviors
Of the 13 studies that examined the effects of exogenous oxytocin on dietary intake and behavior, the majority of studies (n ¼ 8) [43] [44] [45] 60, 61, 65, 70, 71 administered oxytocin intranasally (Table 2 42-45,52-71 ). All but 1 study 69 examined oxytocin in relation to a placebo (nasal spray containing the same ingredients as the treatment spray except for oxytocin, or a saline infusion). The composition of the placebo nasal spray was not specified in 2 studies. 43, 65 Mid-to high-range doses of oxytocin 50, [72] [73] [74] were administered; intranasal dosages ranged from 24 to 40 IU, [43] [44] [45] 60, 61, 65, 70 and oxytocin infusions ranged from 20 to 160 mU/min 53, 54, 67 There were no major side-effects reported. This is consistent with prior research in which short-term use of dosage amounts up to 40 IU (per dose) have been prescribed. 75 Only 3 studies 44, 54, 70 determined the change in oxytocin values Beer intake: 497 6 133 mL (range, 288-900 mL). Maximal BAC after nonalcoholic beer intake Alcoholic beer (dose
did not alter plasma OT in healthy male and female participants Neutral (continued) from baseline following oxytocin administration. These were not directly comparable because of the differing types of biological samples (ie, saliva and plasma) and reporting methods used. Two of the 9 crossover studies that involved eumenorrheic female participants were conducted during the follicular phase of the menstrual cycle, 60,61 and 1 study was conducted during the follicular or luteal phase. 70 Menstrual cycle phase was not included in the remaining 7 studies. 53, 54, 65, 67, 71 In the crossover studies (n ¼ 12), experimental sessions were mostly conducted following an overnight fast (n ¼ 8). [43] [44] [45] 53, 54, 67 Outcomes of included exogenous studies are detailed in Table 4 . [43] [44] [45] 53, 54, 60, 61, 65, 67, 70, 71 Appetite and satiety
Of the studies that examined the effects of exogenous oxytocin on subjective appetite and satiety (n ¼ 8), 7 studies 43-45,53,54,67 found no effect in healthy participants, diabetic individuals with gastroparesis, or those with functional dyspepsia. In contrast, Borg et al. 54 reported oxytocin (40 mU/min) decreased satiety scores after a liquid meal in healthy male and female participants.
Consummatory behavior
Of the studies that examined consummatory behaviors (n ¼ 6), the administration of intranasal oxytocin had a positive effect on dietary intake in normal-weight 43, 44 (n ¼ 2 studies) and overweight/obese male individuals (n ¼ 3 studies). [43] [44] [45] This included a reduction in hunger-driven food consumption (decrease in overall caloric intake); a reduction in postprandial rewarddriven snack consumption (decrease in total snack and sweet snack intake); and an increase in perceived palatability of bland snacks (n ¼ 2 studies), 43, 45 but not sweet or salty snacks. Energy expenditure, assessed in 3 studies as a secondary measure by indirect calorimetry, was comparable between the placebo and the oxytocin condition during the entire experimental periods. [43] [44] [45] A positive effect, in individuals with BN, was also observed, with a decrease in their 24-hour food intake after oxytocin administration. 60 Oxytocin had no effect on hunger-driven food intake in 2 studies in normalweight men. 43, 45 It also had no effect on volume of liquid meal intake in individuals with functional dyspepsia, 53 consumption of fruit juice in individuals with AN or BN, 60, 61 or binge-eating episodes in individuals with BED. 71 
Craving and attentional biases
Across the 4 studies 61, 65, 70, 71 that examined craving and attentional biases, oxytocin had no effect on cueinduced alcohol craving but did have a positive effect on approach bias toward palatable food images in those with alcohol use disorder. 65 A decrease in attentional biases toward eating and negative shape (fat) stimuli was found in individuals with AN. 61 A neuroimaging study in healthy female participants 70 found oxytocin reduced cravings toward palatable foods when the longterm consequences of eating high-calorie foods were thought about. No effect was found when participants thought about the immediate consequences of eating these foods. Oxytocin had no effect on reducing cravings in individuals with BED. 71 
Effect sizes
Effect sizes were only provided for 4 studies. 60, 61, 65, 70 Moderate to large effect sizes were found in 2 studies in disordered eating population groups. Specifically, oxytocin had moderate (ie, d ! 0.5 to < 0.8) and large (ie, ! 0.8) effect sizes on reducing attentional biases toward negative shape stimuli (d ¼ 0.52) and eating-related stimuli in individuals with AN (d ¼ 0.81) 61 and on reducing calorie consumption in individuals with BN (d ¼ 0.56). 60 The remaining 2 studies found the administration of oxytocin had a small (ie, 0.20 to < 0.5) effect on improving cognitive control of food craving in females when the long-term consequences of eating high calorie foods where thought of (d ¼ 0.15) 70 and a small effect on reducing approach bias to images of palatable food items 65 in individuals with alcohol abuse disorder (d ¼ 0.21).
DISCUSSION
This review evaluated food intake and eating behavior characteristics in relation to endogenous and exogenous oxytocin. The number of studies identified in each area was modest. The bulk of previously published literature regarding oxytocin and nutritional behaviors in humans has been narrative reviews as opposed to experimental or observational studies. 76 The majority of studies included in this review were intervention studies (n ¼ 22), with many using an experimental within-subject crossover design (n ¼ 19). The remaining studies (n ¼ 4) were cross-sectional. Notably, all of the exogenous intervention studies were published after 2005. In comparison, 6 endogenous studies were published before this time. This may be reflective of the gaining interest in oxytocin in general 29 and also as a possible treatment for nutritional-related behaviors and disorders. This Positive for food intake; neutral for appetite (continued) shown. Recorded 72-h food intake prior to OT/placebo experiments did not differ between groups (P > 0.05) estimate (pg/mL)
3.8, P ¼ 0.03. NS after controlling for multiple comparisons. OT had no effect on appetite scores
Food intake, hunger and thirst tics not reported). OT had no effect on hunger (P > 0.9) or thirst ratings (P > 0.12). OT reduced reward-driven total food intake (F (1, 19 ) ¼5.5, P < 0.03), 25% # in sweet snack consumption (P < 0.01)
Neutral for hunger-driven food intake, hunger, and thirst ratings; positive for reward-driven food intake
Food intake, hunger and thirst pattern parallels substance addiction research, whereby oxytocin is now being explored as a new treatment for drug and alcohol addiction. 4, 77 Overall, the majority of included studies comprised small sample sizes of participants aged <45 years and predominantly female; more than half of the studies were conducted in populations with comorbidities. This limits the generalizability of findings to broader populations. With respect to the primary objectives of this review, it was found that in general endogenous oxytocin levels in nonclinical samples were mostly unaltered by dietary intake patterns or behaviors (neutral effect), whereas in clinical samples significant (P > 0.05) alterations (increases and decreases) were found. Overall, exogenous oxytocin had a positive effect in nonclinical samples by reducing indices of food intake. In clinical samples, positive improvements in eating attitudes were found.
The dietary intervention studies that assessed endogenous oxytocin (n ¼ 9) found that the intake of a fat-rich meal increased plasma oxytocin levels, whereas the intake of alcohol, low-and high-sodium diets, or short-term fasting did not change oxytocin levels. One cross-sectional study found no association between the intake of alcohol, caffeine, or calcium and endogenous plasma oxytocin levels in healthy individuals. In contrast, in female participants with T1DM, alcohol use was negatively associated with plasma oxytocin levels, and caffeine intake and calcium supplement use were positively associated. Mean baseline oxytocin levels in female participants with T1DM were found to be lower than those of healthy controls. This highlights the complexity of dietary intakes, which comprise multiple nutrients, and possible influences on neuropeptides within the different population groups found in this review.
Several of the included endogenous studies (n ¼ 3) suggest that the oxytocin system becomes dysregulated in AN, resulting in lower peripheral and CSF levels and increased postprandial oxytocin levels. This is consistent with findings from a recent meta-analysis of 4 studies that found levels of endogenous oxytocin were significantly lower in individuals with AN relative to normal-weight controls (P < 0.05). 37 There is some evidence to suggest that over the course of recovery from AN the oxytocin system returns to normal levels. However, this remains inconclusive, with 1 study in this review finding oxytocin levels to be lower in individuals with weight-recovered AN than in individuals with active AN. It is not known whether the changes in oxytocin levels are a consequence of aberrant eating behaviors or malnutrition or whether the existence of premorbid traits increases an individual's vulnerability to developing eating disorders. 66, 78 Interestingly, the current review found plasma oxytocin levels in individuals with BN were similar to those in healthy controls. Abstinence from binge eating and purging in this population had no effect on oxytocin levels. In this review, obese individuals with and without food addiction displayed similar levels of plasma oxytocin (n ¼ 1 study). However, the study sample was predominantly female, and it is unknown whether blood collections were standardized for menstrual cycle phase. It has previously been reported that obese individuals have significantly lower serum oxytocin concentrations than normal-weight individuals (P < 0.01). 79 To further examine the influence of food addiction on oxytocin outcomes, future studies would benefit from the inclusion of both healthy weight and overweight/obese groups.
The current review found a single-dose (40 IU) of exogenously administered oxytocin exerted a favorable effect on reducing biases to food stimuli (n ¼ 2) in individuals with AN and individuals with alcohol use disorder. However, oxytocin did not have a significant effect on alcohol cravings (n ¼ 1; P > 0.05). A single-dose (24 IU) of oxytocin was also found to improve cognitive control of food cravings in a sample of healthy normalweight female participants. In contrast, the chronic administration (24 IU 4Â/d) of oxytocin in individuals with BED had no effect on cravings or binge-eating episodes. There was little evidence to support the use of exogenous oxytocin in modulating satiety (the sensation of fullness). Four studies found that oxytocin had no effect on satiety outcomes. Unexpectedly, 1 study found that oxytocin (40 IU) reduced instead of increased the sensation of satiety. However, it should be noted that some of the dietary assessment measures (eg, Visual Analogue Scales, surveys) used in these studies may be associated with self-reporting bias.
Exogenous oxytocin produced positive changes in food intake behavior in healthy individuals and female participants with BN. A single-dose (24 IU) of oxytocin reduced hunger-driven food intake, without affecting subjective appetite, in overweight/obese male participants. However, of the 2 studies that included normalweight male participants, only 1 found a reduction in hunger-driven food intake. Correspondingly, oxytocin has been found to have a more pronounced anorexigenic effect in diet-induced obese rats compared with control rats. 80 The current review found oxytocindecreased high-sugar snack consumption in human male participants, irrespective of weight status. These findings are consistent with animal studies [81] [82] [83] that have suggested that the effects of oxytocin on limiting consumption of sugar may extend to humans. At this time, the exact biological mechanisms of oxytocin remain unknown. However, exogenous oxytocin delivery may act to improve glucose tolerance through actions in the periphery; for example, in the pancreas or via fat metabolism. Although exogenous oxytocin does have limitations for direct use in humans, such as a short half-life (%1-6 min) 29, 48 and possible off-target effects 35 (eg, antisocial behaviors such as increased aggression, 84 decreased trust, and decreased cooperation 85 ), overall the studies in this review cound no adverse side effects.
The majority of the included studies (n ¼ 17) investigated only 1 aspect of dietary intake (eg, calorie intake, alcohol intake), and the dietary assessment tools used were not specified for most. The included studies represent a wide variety of study designs, and for this reason a wide variety of dietary assessment tools were used and, subsequently, a range of dietary outcomes reported. It is acknowledged that different dietary assessment tools are appropriate and useful in different research settings (ie, epidemiological research, clinical settings, and laboratory-based experiments). The choice of dietary assessment tool is dependent on numerous factors, including the outcome of interest (energy intake, food groups, amount of food), population group, budget, time, and both participant and researcher burden. In a number of the dietary intervention studies (n ¼ 6), the applied intervention doses exceeded national nutritional recommendations. For instance, 4 studies provided an intervention dose of alcohol exceeding the current recommendation of 2 standard drinks (20 g of alcohol) per day. 86 One study exposed participants to a short-term high-sodium diet. The intervention diet, which contained 5290 mg of sodium per day, exceeded the suggested dietary target (1600 mg/d) by 230%. 87 Prescribing participants a highlevel intervention dose limits the generalizability, translation, and clinical significance of findings. This does not allow for experimental replication in longer term feeding trials.
Plasma oxytocin values varied markedly across studies, which is likely due to the various analysis techniques used. Szeto et al. 48 reported that sample extraction is necessary to obtain valid assay results because plasma oxytocin levels by enzyme immunoassay can be >100-fold higher than the same extracted sample, and radioimmunoassay of unextracted plasma can have values that are 10-fold higher than the extracted sample. A gold-standard methodology for oxytocin measurement may facilitate further research in this area and may help resolve existing controversies. 48, 49 In animal models, oxytocin levels can be measured and manipulated through a number of experimental approaches 88 not possible in humans. For example, the effects on eating behavior can be assessed after the targeted delivery of synthetic oxytocin or receptor antagonists or in genetically modified animals in which oxytocin genes or receptors are knocked down or overexpressed. 37 Because these approaches involve invasive procedures, they are generally not feasible in humans, and researchers in human studies often rely on peripheral oxytocin measurements, such as plasma or saliva, as proxy measures. 37 Further work is required to determine whether circulating blood level of oxytocin is an accurate measurement of central nervous system release and activity. Findings from a recent meta-analysis of human and animal studies (n ¼ 17) 89 indicate that peripheral oxytocin levels used to estimate central nervous system levels under basal conditions must be interpreted with caution. This may be due to variability in the sensitivity of the currently available immunoassays. Notably, a positive association between central and peripheral concentrations after the intranasal administration of oxytocin was found (r ¼ 0.66; P < 0.0001). 89 Further, it has been reported that oxytocin delivered intranasally has the ability to enter the brain via uptake through the olfactory and/or trigeminal nerves in the nasal epithelium. 65, 90, 91 Peripheral measurements remain informative because oxytocin released in the circulation from the pituitary gland would have effects on oxytocin receptors in peripheral tissues and potentially produce central effects via the vagus nerve.
A number of recommendations for future research to further understand the complex interrelationship between diet and oxytocin arise from this review. First, given how complex dietary intakes can be and the substantial variation that can occur in day-to-day intake, where possible (dependent on factors such as study design and outcome of interest) population-specific validated tools, such as food frequency questionnaires, or standardized measures, such as multiple-pass 24-hour recall, should be used to comprehensively and accurately capture usual dietary intakes. These tools will be valuable to provide a more holistic approach when evaluating the possible range of effects of exogenous oxytocin on dietary intake and assessing correlations between endogenous oxytocin levels and specific nutrients or aspects of food intake. Importantly, the use of validated dietary assessment tools will allow for reproducibility in subsequent trials and translation. The use of standardized reporting guidelines, such as Strengthening the Reporting of Observational Studies in Nutritional Epidemiology (STROBE-nut), 92 may assist in improving the reporting of methods used for the assessment of dietary intake. Consideration should also be given to dietary intervention dosages. Applications of dosages comparable with recommended intakes of nutrients or amounts commonly consumed by populations will make results more generalizable. Second, the findings of this review point to the need for longer-term intervention studies in larger sample sizes to evaluate the relationship between nutrients or foods with changes in oxytocin concentrations over time. Studies evaluating the longer-term effects of exogenous oxytocin on dietary intake patterns and consequent alterations in eating behaviors are also needed to extend the current findings. Additionally, clinical studies will benefit from measuring endogenous oxytocin levels in conjunction with oxytocin administration to determine how endogenous oxytocin levels respond. Third, standardizing the menstrual cycle phase during which female participants are tested will minimize possible confounding effects due to hormonal variations. This review was limited to studies published in English; contributions outside of these parameters may have been missed. The limitations of this paper relate primarily to the quality of evidence that is presently available. The sample size of most studies was small, and the majority of studies were performed in younger adult population groups. The majority of participants in the identified studies were female, which makes it unclear whether the relationships observed in the current review will generalize to male participants. Fasting times and menstrual phase were not always reported and accounted for in the study design, which may potentially influence the findings. Finally, the pronounced heterogeneity in study designs hinders cross-study comparisons. Given these limitations and the small number of studies currently available for these outcomes, it is important to view these results with caution. This is the first systematic review to investigate oxytocin in relation to dietary intakes and behaviors. A strength of this paper is its rigorous systematic methodology. The search strategy was developed in consultation with an experienced research librarian, and the screening process included 3 independent reviewers who came to consensus on all included studies. Quality of the evidence was assessed using a standardized tool. Finally, the paper was prospectively registered with PROSPERO.
CONCLUSION
Evidence to pursue investigations into the role of oxytocin in dietary behaviors is accumulating. Currently, this analysis supports a role for exogenous oxytocin delivery in the negative regulation of food intake. Although the exact mechanisms are yet to be determined, exogenous oxytocin may have positive effects on dietary behaviors via periphery actions involved in metabolism. It is also possible that oxytocin may feed back to central sites involved with reward and energy expenditure. At this time, it is unclear whether lower basal levels of oxytocin observed in individuals with clinical comorbidities, such as T1DM or disordered eating (eg, AN and BN) are caused by dysregulation of oxytocin pathways. To further examine dietary effects on endogenous oxytocin where appropriate (ie, dependent on study design and outcome measures), more comprehensive investigations of dietary intakes, using validated assessment tools, in larger sample sizes is required. In addition, longer-term feeding trials with consideration given to intervention dosages of nutrients that are more aligned with population consumption levels will be of importance. Studies seeking to further understand the neurobiological basis for oxytocin-induced suppression of food intake would also seem warranted. premise. 
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